Skip to content

Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions

Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03682198
Enrollment
18
Registered
2018-09-24
Start date
2018-09-24
Completion date
2020-10-01
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective Craniotomy, General Anaesthesia, Neurosurgery

Brief summary

This is a prospective observational study, consisting of 3 substudies carried out during elective neurosurgery under general anaesthesia. Each participant will take part in all 3 substudies. First, the capability of Near Infra Red Spectroscopy (NIRS) to measure the brain oxygenation is examined. A NIRS-electrode is placed on forehead skin, on the skull, and on dura. Secondly, a small dose of Phenylephrine is given, and the brain oxygenation is measured by a Clark-electrode and a NIRS-electrode, to see how Phenylephrine affects these measurements. In the third substudy, the brain oxygenations' (NIRS and Licox) response to an inspired oxygen fraction of 0.30 vs. 0.80 is investigated.

Interventions

DEVICENIRS measurements on skin, skull and dura

During a neurosurgical procedure, we will measure the brain oxygenation with a NIRS-electrode, first on forehead skin, then on the skull and finally directly on dura.

DRUGPhenylephrine's effect on brain oxygenation

With a Clark-electrode (Licox(R)) in the white matter and a NIRS-electrode on the forehead skin, we will give a small dose (0.1 mg iv.) Phenylephrine.

DRUGNormal vs. high inspired oxygen

By the end of the neurosurgical procedure, still with a Clark-electrode in the white matter and a NIRS-electrode on forehead skin, we will change the inspired oxygen fraction from 0.3 to 0.8.

Sponsors

University Hospital Bispebjerg and Frederiksberg
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult (\>18 years) patients * Elective craniotomy

Exclusion criteria

* Repeat craniotomy * Preoperative hypotension (defined as systolic blood pressure below 110 mmHg) * Preoperative hypoxia (defined as peripheral oxygen saturation (SpO2) \< 90% without oxygen supplementation before surgery) * No negative pregnancy test for women \<50 years.

Design outcomes

Primary

MeasureTime frameDescription
ScO2 (NIRS-measured cerebral oxygen saturation)During surgical procedureDifference in ScO2 between dura and skin (Primary analysis for substudy 1)

Secondary

MeasureTime frameDescription
PBrO2 (Partial pressure of brain tissue oxygen)During surgical procedureCerebral oxygenation, measured by a Clark-electrode (Licox (R)) (Primary outcome measure for substudy 2)
ScO2 (NIRS-measured cerebral oxygen saturation)Measurements will be performed as the surgeon exposes the skull.Difference in ScO2 between dura and skull, and between skull and skin (this will be the secondary analyses of substudy 1)
ScO2 (NIRS-measured cerebral oxygenation)NIRS signal is obtained continuously during the Phenylephrine interventionNIRS-signal during Phenylephrine intervention (this will be the secondary outcome of substudy 2)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026